{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T06:21:40Z","timestamp":1780467700521,"version":"3.54.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Eat Disord"],"DOI":"10.1186\/s40337-025-01448-y","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T14:36:08Z","timestamp":1765290968000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Ketamine for treatment resistant depression in individuals with eating disorders: a comparison study"],"prefix":"10.1186","volume":"13","author":[{"given":"Elizabeth","family":"Wassenaar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan V.","family":"Blalock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Duffy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Riddle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Marie","family":"O\u2019Melia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Weeks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip S.","family":"Mehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee D.","family":"Rienecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"issue":"3","key":"1448_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/wps.21120","volume":"22","author":"RS McIntyre","year":"2023","unstructured":"McIntyre RS, Alsuwaidan M, Baune BT, Berk M, Demyttenaere K, Goldberg JF, et al. Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions. World Psychiatry. 2023;22(3):394\u2013412.","journal-title":"World Psychiatry"},{"issue":"2","key":"1448_CR2","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/wps.20128","volume":"13","author":"E Chesney","year":"2014","unstructured":"Chesney E, Goodwin GM, Fazel S. Risks of all-cause and suicide mortality in mental disorders: a meta-review. World Psychiatry. 2014;13(2):153\u201360.","journal-title":"World Psychiatry"},{"issue":"7","key":"1448_CR3","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1176\/appi.ajp.20240706","volume":"182","author":"TJ Bommersbach","year":"2025","unstructured":"Bommersbach TJ, Olfson M, Rhee TG. National trends in suicidal thoughts and suicide attempts among high school students in the United States. AJP. 2025;182(7):639\u201359.","journal-title":"AJP"},{"issue":"1","key":"1448_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/(SICI)1098-108X(199901)25:1<11::AID-EAT2>3.0.CO;2-U","volume":"25","author":"CP Ferguson","year":"1999","unstructured":"Ferguson CP, La Via MC, Crossan PJ, Kaye WH. Are serotonin selective reuptake inhibitors effective in underweight anorexia nervosa? Int J Eat Disord. 1999;25(1):11\u20137.","journal-title":"Int J Eat Disord"},{"issue":"3","key":"1448_CR5","doi-asserted-by":"publisher","first-page":"127","DOI":"10.9740\/mhc.2018.05.127","volume":"8","author":"M Marvanova","year":"2018","unstructured":"Marvanova M, Gramith K. Role of antidepressants in the treatment of adults with anorexia nervosa. Ment Health Clin. 2018;8(3):127\u201337.","journal-title":"Ment Health Clin"},{"issue":"3","key":"1448_CR6","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s43440-020-00097-z","volume":"72","author":"J Kryst","year":"2020","unstructured":"Kryst J, Kawalec P, Mitoraj AM, Pilc A, Laso\u0144 W, Brzostek T. Efficacy of single and repeated administration of ketamine in unipolar and bipolar depression: a meta-analysis of randomized clinical trials. Pharmacol Rep. 2020;72(3):543\u201362.","journal-title":"Pharmacol Rep"},{"key":"1448_CR7","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jpsychires.2018.09.013","volume":"106","author":"W Zheng","year":"2018","unstructured":"Zheng W, Zhou YL, Liu WJ, Wang CY, Zhan YN, Li HQ, et al. Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression. J Psychiatr Res. 2018;106:61\u20138.","journal-title":"J Psychiatr Res"},{"issue":"8","key":"1448_CR8","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","volume":"63","author":"CA Zarate","year":"2006","unstructured":"Zarate CA, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, et al. A randomized trial of an n-methyl-d-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry. 2006;63(8):856.","journal-title":"Arch Gen Psychiatry"},{"key":"1448_CR9","volume":"62","author":"S Nikolin","year":"2023","unstructured":"Nikolin S, Rodgers A, Schwaab A, Bahji A, Zarate C, Vazquez G, et al. Ketamine for the treatment of major depression: a systematic review and meta-analysis. eClin Med. 2023;62:102127.","journal-title":"eClin Med"},{"issue":"12","key":"1448_CR10","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.biopsych.2014.03.026","volume":"76","author":"KAB Lapidus","year":"2014","unstructured":"Lapidus KAB, Levitch CF, Perez AM, Brallier JW, Parides MK, Soleimani L, et al. A randomized controlled trial of intranasal ketamine in major depressive disorder. Biol Psychiatry. 2014;76(12):970\u20136.","journal-title":"Biol Psychiatry"},{"issue":"06","key":"1448_CR11","doi-asserted-by":"publisher","first-page":"e719","DOI":"10.4088\/JCP.15m10056","volume":"77","author":"DF Ionescu","year":"2016","unstructured":"Ionescu DF, Swee MB, Pavone KJ, Taylor N, Akeju O, Baer L, et al. Rapid and sustained reductions in current suicidal ideation following repeated doses of intravenous ketamine: secondary analysis of an open-label study. J Clin Psychiatry. 2016;77(06):e719\u201325.","journal-title":"J Clin Psychiatry"},{"key":"1448_CR12","unstructured":"Rosenbaum SB, Gupta V, Patel P, Palacios JL. Ketamine. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 [cited 2023 Aug 8]. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK470357\/."},{"key":"1448_CR13","unstructured":"Center for Drug Evaluation and Research. FDA warns patients and health care providers about potential risks associated with compounded ketamine products, including oral formulations, for the treatment of psychiatric disorders. FDA [Internet]. 2023 Oct 10 [cited 2023 Dec 29]; https:\/\/www.fda.gov\/drugs\/human-drug-compounding\/fda-warns-patients-and-health-care-providers-about-potential-risks-associated-compounded-ketamine."},{"issue":"2","key":"1448_CR14","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/cpt.3478","volume":"117","author":"KA Vekhova","year":"2025","unstructured":"Vekhova KA, Namiot ED, Jonsson J, Schi\u00f6th HB. Ketamine and esketamine in clinical trials: FDA- approved and emerging indications, trial trends with putative mechanistic explanations. Clin Pharmacol Ther. 2025;117(2):374\u201386.","journal-title":"Clin Pharmacol Ther"},{"issue":"8","key":"1448_CR15","doi-asserted-by":"publisher","first-page":"3751","DOI":"10.1007\/s40519-022-01455-x","volume":"27","author":"L Calabrese","year":"2022","unstructured":"Calabrese L, Scolnick B, Zupec-Kania B, Beckwith C, Costello K, Frank GKW. Ketogenic diet and ketamine infusion treatment to target chronic persistent eating disorder psychopathology in anorexia nervosa: a pilot study. Eat Weight Disord. 2022;27(8):3751\u20137.","journal-title":"Eat Weight Disord"},{"issue":"1","key":"1448_CR16","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/YCT.0000000000000878","volume":"39","author":"CW Easterly","year":"2023","unstructured":"Easterly CW, Taylor R. Ketamine augmentation of electroconvulsive therapy in an adolescent patient with suicidal ideation, disordered eating, and type 1 diabetes mellitus: a case report. J ECT. 2023;39(1):63\u20134.","journal-title":"J ECT"},{"key":"1448_CR17","doi-asserted-by":"publisher","first-page":"1181447","DOI":"10.3389\/fpsyt.2023.1181447","volume":"14","author":"JL Keeler","year":"2023","unstructured":"Keeler JL, Treasure J, Himmerich H, Brendle M, Moore C, Robison R. Case report: Intramuscular ketamine or intranasal esketamine as a treatment in four patients with major depressive disorder and comorbid anorexia nervosa. Front Psychiatry. 2023;14:1181447.","journal-title":"Front Psychiatry"},{"issue":"7","key":"1448_CR18","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/qjmed\/91.7.493","volume":"91","author":"I Mills","year":"1998","unstructured":"Mills I. Treatment of compulsive behaviour in eating disorders with intermittent ketamine infusions. QJM. 1998;91(7):493\u2013503.","journal-title":"QJM"},{"issue":"12","key":"1448_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.764112","volume":"17","author":"A Ragnhildstveit","year":"2021","unstructured":"Ragnhildstveit A, Jackson LK, Cunningham S, Good L, Tanner Q, Roughan M, et al. Case report: unexpected remission from extreme and enduring bulimia nervosa with repeated ketamine assisted psychotherapy. Front Psychiatry. 2021;17(12):764112.","journal-title":"Front Psychiatry"},{"issue":"1","key":"1448_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s40337-022-00588-9","volume":"10","author":"R Robison","year":"2022","unstructured":"Robison R, Lafrance A, Brendle M, Smith M, Moore C, Ahuja S, et al. A case series of group-based ketamine-assisted psychotherapy for patients in residential treatment for eating disorders with comorbid depression and anxiety disorders. J Eat Disord. 2022;10(1):65.","journal-title":"J Eat Disord"},{"issue":"11","key":"1448_CR21","doi-asserted-by":"publisher","first-page":"763","DOI":"10.3389\/fpsyt.2020.00763","volume":"30","author":"B Scolnick","year":"2020","unstructured":"Scolnick B, Zupec-Kania B, Calabrese L, Aoki C, Hildebrandt T. Remission from chronic anorexia nervosa with ketogenic diet and ketamine: case report. Front Psychiatry. 2020;30(11):763.","journal-title":"Front Psychiatry"},{"issue":"1","key":"1448_CR22","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s40519-023-01528-5","volume":"28","author":"B Scolnick","year":"2023","unstructured":"Scolnick B, Beckwith C. Synergy between ketamine and ketogenic diet in anorexia nervosa, and other neurobehavioral disorders. Eat Weight Disord. 2023;28(1):8.","journal-title":"Eat Weight Disord"},{"issue":"14","key":"1448_CR23","doi-asserted-by":"publisher","first-page":"1141988","DOI":"10.3389\/fpsyt.2023.1141988","volume":"30","author":"PE Wolfson","year":"2023","unstructured":"Wolfson PE, Andries J, Ahlers D, Whippo M. Ketamine-assisted psychotherapy in adolescents with multiple psychiatric diagnoses. Front Psychiatry. 2023;30(14):1141988.","journal-title":"Front Psychiatry"},{"issue":"1","key":"1448_CR24","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s40337-024-01039-3","volume":"12","author":"A Timek","year":"2024","unstructured":"Timek A, Daniels-Brady C, Ferrando S. Improvement in depressive symptoms in a patient with severe and enduring anorexia nervosa and comorbid major depressive disorder using psychotherapy-assisted IV ketamine\u202f: a case report. J Eat Disord. 2024;12(1):79.","journal-title":"J Eat Disord"},{"key":"1448_CR25","doi-asserted-by":"crossref","unstructured":"Dechant E, Boyle B, A Ross R. Ketamine in a Patient with Comorbid Anorexia and MDD. J Women\u2019s Health Dev [Internet]. 2020 [cited 2025 May 11];03(03). http:\/\/www.fortunejournals.com\/articles\/ketamine-in-a-patient-with-comorbid-anorexia-and-mdd.html.","DOI":"10.26502\/fjwhd.2644-28840044"},{"key":"1448_CR26","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jpsychires.2025.05.055","volume":"188","author":"E Wassenaar","year":"2025","unstructured":"Wassenaar E, Blalock DV, Duffy A, Riddle M, Weeks H, Mehler P, et al. Is ketamine safe for individuals in higher level of care treatment for eating disorders? Analysis of safety of subanesthetic ketamine in 104 patients. J Psychiatr Res. 2025;188:52\u20136.","journal-title":"J Psychiatr Res"},{"issue":"1","key":"1448_CR27","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s40337-024-01150-5","volume":"12","author":"RD Rienecke","year":"2024","unstructured":"Rienecke RD, Blalock DV, Duffy A, Johnson C, Riddle M, Le Grange D, et al. Does 24\/7 care result in better outcomes for adults with eating disorders? A comparison of inpatient\/residential care to partial hospitalization\/intensive outpatient care for patients at low BMIs. J Eat Disord. 2024;12(1):184.","journal-title":"J Eat Disord"},{"key":"1448_CR28","first-page":"620","volume-title":"Eating disorders: a comprehensive guide to medical care and complications","year":"2022","unstructured":"Mehler PS, Andersen AE, editors. Eating disorders: a comprehensive guide to medical care and complications. 4th ed. Baltimore: Johns Hopkins University Press; 2022. p. 620.","edition":"4"},{"key":"1448_CR29","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington: American Psychiatric Publishing; 2013.","edition":"5"},{"issue":"9","key":"1448_CR30","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606\u201313.","journal-title":"J Gen Intern Med"},{"issue":"12","key":"1448_CR31","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1176\/appi.ps.201200587","volume":"64","author":"GE Simon","year":"2013","unstructured":"Simon GE, Rutter CM, Peterson D, Oliver M, Whiteside U, Operskalski B, et al. Does response on the PHQ-9 depression questionnaire predict subsequent suicide attempt or suicide death? PS. 2013;64(12):1195\u2013202.","journal-title":"PS"},{"key":"1448_CR32","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jad.2015.12.075","volume":"193","author":"C Beard","year":"2016","unstructured":"Beard C, Hsu KJ, Rifkin LS, Busch AB, Bj\u00f6rgvinsson T. Validation of the PHQ-9 in a psychiatric sample. J Affect Disord. 2016;193:267\u201373.","journal-title":"J Affect Disord"},{"issue":"10","key":"1448_CR33","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","volume":"166","author":"RL Spitzer","year":"2006","unstructured":"Spitzer RL, Kroenke K, Williams JBW, L\u00f6we B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092.","journal-title":"Arch Intern Med"},{"issue":"10","key":"1448_CR34","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.3389\/fpsyg.2019.01713","volume":"6","author":"SU Johnson","year":"2019","unstructured":"Johnson SU, Ulvenes PG, \u00d8ktedalen T, Hoffart A. Psychometric properties of the general anxiety disorder 7-item (GAD-7) scale in a heterogeneous psychiatric sample. Front Psychol. 2019;6(10):1713.","journal-title":"Front Psychol"},{"issue":"3","key":"1448_CR35","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1002\/eat.20931","volume":"45","author":"KC Berg","year":"2012","unstructured":"Berg KC, Peterson CB, Frazier P, Crow SJ. Psychometric evaluation of the eating disorder examination and eating disorder examination-questionnaire: a systematic review of the literature. Intl J Eat Disord. 2012;45(3):428\u201338.","journal-title":"Intl J Eat Disord"},{"issue":"6","key":"1448_CR36","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.apnu.2017.08.002","volume":"31","author":"KM Jennings","year":"2017","unstructured":"Jennings KM, Phillips KE. Eating disorder examination-questionnaire (EDE-Q): norms for clinical sample of female adolescents with anorexia nervosa. Arch Psychiatr Nurs. 2017;31(6):578\u201381.","journal-title":"Arch Psychiatr Nurs"},{"issue":"25","key":"1448_CR37","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1002\/sim.3697","volume":"28","author":"PC Austin","year":"2009","unstructured":"Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009;28(25):3083\u2013107.","journal-title":"Stat Med"},{"key":"1448_CR38","unstructured":"Yoshida K, Bohn J. Create \u201cTable 1\u201d to Describe Baseline Characteristics with or without Propensity Score Weights [Internet]. 2022 [cited 2024 Jan 17]. https:\/\/github.com\/kaz-yos\/tableone."},{"key":"1448_CR39","unstructured":"R Core Team. R: A language and environment for statistical computing. [Internet]. 2024. https:\/\/www.r-project.org\/."},{"issue":"1","key":"1448_CR40","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40337-022-00568-z","volume":"10","author":"C Vinchenzo","year":"2022","unstructured":"Vinchenzo C, Lawrence V, McCombie C. Patient perspectives on premature termination of eating disorder treatment: a systematic review and qualitative synthesis. J Eat Disord. 2022;10(1):39.","journal-title":"J Eat Disord"},{"issue":"2","key":"1448_CR41","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/erv.2879","volume":"30","author":"L Thaler","year":"2022","unstructured":"Thaler L, Booij L, Burnham N, Kenny S, Oliverio S, Israel M, et al. Predictors of non-completion of a day treatment program for adults with eating disorders. Eur Eat Disord Rev. 2022;30(2):146\u201355.","journal-title":"Eur Eat Disord Rev"},{"issue":"1","key":"1448_CR42","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s40337-023-00934-5","volume":"11","author":"S Smith","year":"2023","unstructured":"Smith S, Sutandar K, Woodside B. Premature termination of inpatient eating disorder treatment: Does timing matter? J Eat Disord. 2023;11(1):210.","journal-title":"J Eat Disord"},{"issue":"1","key":"1448_CR43","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s40337-023-00833-9","volume":"11","author":"SC Rodan","year":"2023","unstructured":"Rodan SC, Bryant E, Le A, Maloney D, Touyz S, McGregor IS, et al. Pharmacotherapy, alternative and adjunctive therapies for eating disorders: findings from a rapid review. J Eat Disord. 2023;11(1):112.","journal-title":"J Eat Disord"},{"issue":"308","key":"1448_CR44","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jad.2022.04.020","volume":"1","author":"A Bayes","year":"2022","unstructured":"Bayes A, Short B, Zarate CA, Park L, Murrough JW, McLoughlin DM, et al. The Ketamine Side Effect Tool (KSET): A comprehensive measurement-based safety tool for ketamine treatment in psychiatry. J Affect Disord. 2022;1(308):44\u20136.","journal-title":"J Affect Disord"},{"key":"1448_CR45","unstructured":"ASKP3. ASKP3 Standards of Practice and Ethics Statement 2020 [Internet]. Presentation presented at; 2020 [cited 2025 June 1]. https:\/\/www.askp.org\/."},{"key":"1448_CR46","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.jpsychires.2022.04.035","volume":"151","author":"TT Le","year":"2022","unstructured":"Le TT, Cordero IP, Jawad MY, Swainson J, Di Vincenzo JD, Jaberi S, et al. The abuse liability of ketamine: a scoping review of preclinical and clinical studies. J Psychiatr Res. 2022;151:476\u201396.","journal-title":"J Psychiatr Res"},{"key":"1448_CR47","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3389\/fpsyt.2020.00311","volume":"11","author":"F Pinna","year":"2020","unstructured":"Pinna F, Manchia M, Paribello P, Carpiniello B. The impact of Alexithymia on treatment response in psychiatric disorders: a systematic review. Front Psychiatry. 2020;11:311.","journal-title":"Front Psychiatry"},{"issue":"1","key":"1448_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/2050-2974-1-21","volume":"1","author":"ME Nowakowski","year":"2013","unstructured":"Nowakowski ME, McFarlane T, Cassin S. Alexithymia and eating disorders: a critical review of the literature. J Eat Disord. 2013;1(1):21.","journal-title":"J Eat Disord"},{"issue":"3","key":"1448_CR49","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3390\/brainsci12030382","volume":"12","author":"A Ragnhildstveit","year":"2022","unstructured":"Ragnhildstveit A, Slayton M, Jackson LK, Brendle M, Ahuja S, Holle W, et al. Ketamine as a novel psychopharmacotherapy for eating disorders: evidence and future directions. Brain Sci. 2022;12(3):382.","journal-title":"Brain Sci"},{"issue":"10445","key":"1448_CR50","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1016\/S0140-6736(24)00874-2","volume":"403","author":"H Himmerich","year":"2024","unstructured":"Himmerich H, Keeler JL, Davies HL, Tessema SA, Treasure J. The evolving profile of eating disorders and their treatment in a changing and globalised world. Lancet. 2024;403(10445):2671\u20135.","journal-title":"Lancet"},{"issue":"4","key":"1448_CR51","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1017\/S0033291718002088","volume":"49","author":"SB Murray","year":"2019","unstructured":"Murray SB, Quintana DS, Loeb KL, Griffiths S, Le Grange D. Treatment outcomes for anorexia nervosa: a systematic review and meta-analysis of randomized controlled trials. Psychol Med. 2019;49(4):535\u201344.","journal-title":"Psychol Med"},{"key":"1448_CR52","doi-asserted-by":"crossref","unstructured":"Szigeti B. \u2018Equal-unblinding\u2019 meta-analysis of psychedelic therapy vs. antidepressants for the treatment of depression [Internet]. PsyArXiv; 2025 [cited 2025 Aug 18]. https:\/\/osf.io\/vhs4a_v1.","DOI":"10.31234\/osf.io\/vhs4a_v1"}],"container-title":["Journal of Eating Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40337-025-01448-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40337-025-01448-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40337-025-01448-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T16:03:12Z","timestamp":1765296192000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeatdisord.biomedcentral.com\/articles\/10.1186\/s40337-025-01448-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1448"],"URL":"https:\/\/doi.org\/10.1186\/s40337-025-01448-y","relation":{},"ISSN":["2050-2974"],"issn-type":[{"value":"2050-2974","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,9]]},"assertion":[{"value":"3 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Participants provided informed consent for this study as part of a larger outcomes study prior to completing measures. For participants who received ketamine, they provided additional informed consent to receive the medication. This study was reviewed and received expedited approval by Salus Institutional Review Board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"280"}}